The medical route to market approval in the UK – the pros and cons

Products that can prove their efficacy in treating smoking addiction can pursue a medical licence route in the UK. The MHRA, Britain’s pharmaceutical regulator, is currently encouraging and supporting companies to submit medicines authorisation applications for e-cigarette products.

This route offers both advantages and disadvantages. Though quite costly and time-consuming, it enables producers and sellers to make health claims and sidestep product restrictions imposed on tobacco-related e-cigarette products.

This regulatory report from ECigIntelligence explains how the process works, and examines the pros and cons.

I'm already a subscriber
Author default picture

Elba Manzanilla Zapata

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization